Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy

被引:0
|
作者
Binquet, C
Saillour, F
Bernard, N
Marimoutou, C
Dabis, F
机构
[1] Univ Bordeaux 2, Unite INSERM 330, F-33076 Bordeaux, France
[2] Ctr Hosp Univ, Hop St Andre, Bordeaux, France
[3] Ctr Hosp Univ, Ctr Informat & Soins Immunodeficience Humaine, Bordeaux, France
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2502 / 2504
页数:3
相关论文
共 50 条
  • [1] Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy
    Doan, S
    Cochereau, I
    Guvenisik, N
    Diraison, MC
    Mousalatti, H
    Hoang-Xuan, T
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (02) : 250 - 251
  • [2] Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
    Jouan, M
    Savès, M
    Tubiana, R
    Carcelain, G
    Cassoux, N
    Aubron-Olivier, C
    Fillet, AM
    Nciri, M
    Sénéchal, B
    Chêne, G
    Tural, C
    Lasry, S
    Autran, B
    Katlama, C
    [J]. AIDS, 2001, 15 (01) : 23 - 31
  • [3] Dyspepsia in HIV-infected patients under highly active antiretroviral therapy
    Werneck-Silva, Ana Luiza
    Prado, Ivete Bedin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1712 - 1716
  • [4] Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV-infected patients - Natural history and clinical predictors
    Lin, DY
    Warren, JF
    Lazzeroni, LC
    Wolitz, RA
    Mansour, SE
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (03): : 268 - 277
  • [5] Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients
    de Olalla, PG
    Knobel, H
    Carmona, A
    Guelar, A
    López-Colomés, JL
    Caylà, JA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (01): : 105 - 110
  • [6] Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients
    Ahuja, TS
    Borucki, M
    Grady, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 574 - 580
  • [7] Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy
    Mazeron, MC
    Fillet, AM
    Salmon, D
    Boukli, N
    Houhou, N
    Sénéchal, B
    Matheron, S
    Gozlan, J
    Leport, C
    Katlama, C
    Scieux, C
    Imbert, BM
    Deny, P
    Bour, JB
    Freymuth, F
    Chanzy, B
    Chaput, S
    Costagliola, D
    [J]. AIDS, 2003, 17 (05) : 784 - 786
  • [8] A Study of Cytomegalovirus Serology among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era
    Sufiawati, Irna
    Widyaputra, Sunardhi
    Djajakusumah, Tony S.
    [J]. MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2013, 45 (02): : 112 - 117
  • [9] The effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Jensen-Fangel, S
    [J]. DANISH MEDICAL BULLETIN, 2004, 51 (04) : 371 - 392
  • [10] PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Tisch, Stephen
    Brew, Bruce
    [J]. NEUROLOGY, 2009, 73 (05) : 401 - 403